Stock & Company Details
Collegium Pharmaceutical Inc $COLL
Price:
46,691,331
32M
$1.2B
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
12.65
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Health Technology
COLL technical indicators
Latest Collegium Pharmaceutical Inc (COLL) technical indicators as of 2026-07-01: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
57.27 3.6%
MACD:
0.54 5.5%
SMA 50:
$34.23 0.1%
SMA 200:
$39.19 0.0%
EMA 20:
$34.78 0.3%
Bollinger Bands:
36.97 / 31.81
Stochastic:
79.32 5.9%
ADX 14:
15.43 6.8%
ATR 14:
1.43 0.3%
CCI 20:
126.14 19.6%
OBV:
39.64M 1.0%
ROC 12:
3.55% 34.4%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol.
Finance Bot
Ask your questions
Start by typing a question below.
